Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure

International Journal of Cardiology

Volumn 258, Issue , 2018, Pages 185-191

  Rubio Gracia, Jorge ^a,b,c   Demissei, Biniyam G ^c   ter Maaten, Jozine M ^c   Cleland, John G ^d   O'Connor, Christopher M ^e   Metra, Marco ^f   Ponikowski, Piotr ^g   Teerlink, John R ^h   Cotter, Gad ⁱ   Davison, Beth A ⁱ   Givertz, Michael M ^j   Bloomfield, Daniel M ^k   Dittrich, Howard ^l   Damman, Kevin ^c   Pérez Calvo, Juan I ^a,b   Voors, Adriaan A ^c  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e INOVA HEART AND VASCULAR INSTITUTE   (United States)

^f UNIVERSITY OF BRESCIA   (Italy)

^g WROCLAW MEDICAL UNIVERSITY   (Poland)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Momentum Research Inc   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k MERCK RESEARCH LABORATORIES   (United States)

^l UNIVERSITY OF IOWA   (United States)

more..

Author keywords

Congestion; Diuretic response; Heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST;

ADULT; ARTICLE; CLINICAL OUTCOME; COHORT ANALYSIS; COMPOSITE CONGESTION SCORE; CONGESTION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEART FAILURE; HEMOCONCENTRATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; ACUTE DISEASE; AGED; CONTROLLED STUDY; HOSPITAL READMISSION; MIDDLE AGED; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

ACUTE DISEASE; ADENOSINE A1 RECEPTOR ANTAGONISTS; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PREVALENCE; TREATMENT OUTCOME;

EID: 85043468026     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2018.01.067     Document Type: Article

References (29)

1. Yancy, C.W., Fonarow, G.C., Committee ASA, Quality of care and outcomes in acute decompensated heart failure: the ADHERE registry. Curr. Heart Fail. Rep. 1 (2004), 121–128.
2. Gheorghiade, M., Filippatos, G., De Luca, L., Burnett, J., Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am. J. Med. 119 (2006), S3–S10.
3. Verbrugge, F.H., Grieten, L., Mullens, W., Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal. Med. 4 (2014), 176–188.
4. Lucas, C., Johnson, W., Hamilton, M.A., et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am. Heart J. 140 (2000), 840–847.
5. Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. J. Heart Fail. 18 (2016), 891–975.
6. Lala, A., McNulty, S.E., Mentz, R.J., et al. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardiorenal rescue study in acute decompensated heart failure (CARESS-HF). Circ. Heart Fail. 8 (2015), 741–748.
7. Ambrosy, A.P., Pang, P.S., Khan, S., et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur. Heart J. 34 (2013), 835–843.
8. Voors, A.A., Ter Maaten, J.M., Tackling early heart failure deaths and readmissions by estimating congestion. JACC Heart Fail. 3 (2015), 894–895.
9. Metra, M., Nodari, S., Parrinello, G., et al. Serial changes and independent prognostic value of NT-proBNP and cardia troponin-T. Eur. J. Heart Fail. 9 (2007), 776–786.
10. Platz, E., Merz, A.A., Jhund, P.S., et al. Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review. Eur. J. Heart Fail., 30, 2017 (Epub ahead of print).
11. Massie, B.M., O'Connor, C.M., Metra, M., et al. PROTECT investigators and committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N. Engl. J. Med. 363 (2010), 1419–1428.
12. ter Maaten, J.M., Valente, M.A., Damman, K., et al. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat. Rev. Cardiol. 12 (2015), 184–192.
13. Voors, A.A., Davison, B.A., Teerlink, J.R., et al. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome–an analysis from RELAX-AHF. Eur. J. Heart Fail. 16 (2014), 1230–1240.
14. Cotter, G., Dittrich, H.C., Weatherley, B.D., et al. Protect steering committee, investigators, and coordinators. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J. Card. Fail. 14 (2008), 631–640.
15. Cleland, J.G., Chiswell, K., Teerlink, J.R., et al. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the placebo-controlled randomized study of the selective A1 adenosine receptor antagonist Rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study. Circ. Heart Fail. 7 (2014), 76–87.
16. Drazner, M.H., Rame, J.E., Stevenson, L.W., Dries, D.L., Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N. Engl. J. Med. 345 (2001), 574–581.
17. Mullens, W., Abrahams, Z., Francis, G.S., et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J. Am. Coll. Cardiol. 53 (2009), 589–596.
18. ter Maaten, J.M., Dunning, A.M., Valente, M.A., et al. Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am. Heart J. 170 (2015), 313–321.
19. Damman, K., Kjekshus, J., Wikstrand, J., et al. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Eur. J. Heart Fail. 18 (2016 Mar), 328–336.
20. Metra, M., Davison, B., Bettari, L., et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ. Heart Fail. 5 (2012), 54–62.
21. Mullens, W., Abrahams, Z., Francis, G.S., et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J. Am. Coll. Cardiol. 53 (2009), 589–596.
22. Damman, K., van Deursen, V.M., Navis, G., et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J. Am. Coll. Cardiol. 53 (2009), 582–588.
23. van Veldhuisen, D.J., Ruilope, L.M., Maisel, A.S., Damman, K., Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure. Eur. Heart J. 37 (2016), 2577–2585.
24. Gheorghiade, M., Filippatos, G., De Luca, L., Burnett, J., Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am. J. Med. 119 (2006), S3–S10.
25. Demissei, B.G., Valente, M.A., Cleland, J.G., et al. Optimizing clinical use of biomarkers in high-risk acute heart failure patients. Eur. J. Heart Fail. 18 (2016), 269–280.
26. Colombo, P.C., Onat, D., Harxhi, A., et al. Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur. Heart J. 35 (2014), 448–454.
27. Tavazzi, L., Maggioni, A.P., Borer, J.S., Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure. Eur. Heart J. 34 (2013), 2792–2794.
28. Valente, M., Voors, A.A., Damman, K., et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur. Heart J. 35 (2014), 1284–1293.
29. Duarte, K., Monnez, J.M., Albuisson, E., et al. Prognostic value of estimated plasma volume in heart failure. JACC Heart Fail. 3 (2015), 886–893.